More about
Ctla-4 Antigen
Clinical Guidance
Immuno-Oncology
Overview
Immune System Signaling Pathways
News
February 06, 2023
4 min watch
Save
VIDEO: Botensilimab, balstilimab combination ‘huge innovation’ in colorectal cancer subset
News
September 09, 2019
3 min read
Save
First-line durvalumab plus chemotherapy improves OS in extensive-stage small cell lung cancer
BARCELONA — The addition of durvalumab to platinum-etoposide chemotherapy significantly extended OS among patients with extensive-stage small cell lung cancer, according to results of the CASPIAN study presented at International Association for the Study of Lung Cancer World Conference on Lung Cancer.